| Wartość aktywów (mln USD): | 345 |
| Liczba spółek: | 25 |
| Stopa dywidendy: | - % |
| Opłata za zarządzanie:: | 0.35 % |
| Klasa aktywów: | Equity |
ISIN: US92189F7261
Wystawca ETF: VanEck| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y |
|---|
| Sektor | Udział % |
|---|---|
| Gotówka | 0.0 |
| Usługi Komercyjne | 7.4 |
| Usługi Zdrowotne | 5.7 |
| Technologie Medyczne | 86.9 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Amgen Inc | AMGN | 50 309 999 | 13.2 | 149 049 |
| Gilead Sciences Inc | GILD | 46 025 408 | 12.1 | 363 435 |
| Vertex Pharmaceuticals Inc | VRTX | 33 803 659 | 8.9 | 79 210 |
| Regeneron Pharmaceuticals Inc | REGN | 22 180 373 | 5.8 | 29 343 |
| Insmed Inc | INSM | 19 994 063 | 5.3 | 100 594 |
| Argenx Se | ARGX | 19 648 347 | 5.2 | 21 382 |
| Natera Inc | NTRA | 19 516 141 | 5.1 | 84 621 |
| Iqvia Holdings Inc | IQV | 17 955 341 | 4.7 | 79 837 |
| Beone Medicines Ltd | ONC | 15 664 090 | 4.1 | 45 048 |
| Alnylam Pharmaceuticals Inc | ALNY | 15 165 514 | 4.0 | 34 753 |
| Biogen Inc | BIIB | 13 644 826 | 3.6 | 77 837 |
| United Therapeutics Corp | UTHR | 13 240 355 | 3.5 | 27 885 |
| Illumina Inc | ILMN | 10 757 487 | 2.8 | 86 859 |
| Icon Plc | ICLR | 10 411 382 | 2.7 | 63 268 |
| Incyte Corp | INCY | 8 874 321 | 2.3 | 86 952 |
| Exact Sciences Corp | EXAS | 8 669 126 | 2.3 | 85 918 |
| Neurocrine Biosciences Inc | NBIX | 8 431 509 | 2.2 | 59 448 |
| Biontech Se | BNTX | 7 588 603 | 2.0 | 79 387 |
| Qiagen Nv | QGEN | 6 198 946 | 1.6 | 132 343 |
| Bio-Techne Corp | TECH | 5 901 034 | 1.6 | 95 905 |
| Moderna Inc | MRNA | 5 531 978 | 1.5 | 233 220 |
| Tempus Ai Inc | TEM | 5 482 338 | 1.4 | 77 996 |
| Repligen Corp | RGEN | 5 089 488 | 1.3 | 31 318 |
| Biomarin Pharmaceutical Inc | BMRN | 4 945 452 | 1.3 | 90 427 |
| Charles River Laboratories Internationa | CRL | 4 662 236 | 1.2 | 27 811 |
| Other/Cash | 252 618 | 0.1 | 0 | |
| -USD CASH.undefined | 89 821 | 0.0 | 89 822 |